Home
Stella Diagnostics

Stella Diagnostics Market Share Analysis for June 2026

optimizing patient management strategies for esophageal diseases

Industry: N/A

Domainstelladx.com

Year Founded2020

Employees51 - 200

Annual Revenue$2M - $5M

Stella Diagnostics

Stella Diagnostics (including company regionals)

stelladx.com

See more website traffic and engagement information

Stella Diagnostics Revenue up to June 2026 is 2M - 5M

revenue generated by Stella Diagnostics top domains

Stella Diagnostics top domains revenue over 3 years

Revenue for Stella Diagnostics top domains

stelladx.com2M - 5M

See more with Sales Intelligence

Total visits to Stella Diagnostics's top domains

Understand Stella Diagnostics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Stella Diagnostics's top domains

Analyze Stella Diagnostics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Stella Diagnostics's top domains

See how Stella Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Stella Diagnostics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Stella Diagnostics

These are the website technologies, by industry, used by Stella Diagnostics top domains

Advertising (1)

DoubleClick

Audio Video Media (1)

YouTube

Conversion & Analytics (1)

Google Analytics

Customer Communication (1)

Stella Service

More Technologies

6

See all

News & Signals from Stella Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsStelladx partnered with KU Medical Center on Mar 16th '21.KANSAS CITY, KS / ACCESSWIRE / March 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") has announced a Collaborative Research Agreement with the University of Kansas Medical Center ("KU Medical Center") to assess the predictability and clinical utility of the Company's STLA101 panel in Barrett's esophagus patients.

NewsKeystone Cp invested into Stelladx on Sep 2nd '20.New York, NY - Keystone Capital Partners ("Keystone") a New York-based investment platform specializing in the biotech, real estate and consumer products sectors, announced today that it has provided the foundational seed capital for Stella Diagnostics ("Stella"), a molecular diagnostics-based organization focused on improving patient management strategies for those living with severe esophageal disease.

NewsStelladx hires Daniel Wainstein as board of directors.As part of the transaction, Daniel Wainstein, Managing Partner and Chief Operating Officer of Keystone, will join Stella’s board of directors.